Stock Taper
EARNINGS CALL ARCHIVE 4 CALLS ON FILE
APYX — Apyx Medical Corporation
NASDAQ
FULL STOCK PAGE →

Q4 2025 Earnings Call Summary

MAR 10, 2026
REVENUE
$19.2M +48.8%
NET MARGIN
-6.8% +8.6 PTS
EPS
-$0.03 +37.1%
FREE CASH FLOW
-$2.8M +30.8%

No summary has been written for this call yet.